CompletedNCT02713204
Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
PHASE2 · 365 planned enrolment
- Countries listed
- 1
- Registry update
- May 7, 2019
